Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Pancreatic cancer clinical trials and accrual in the United States.

Hoos WA, James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM.

J Clin Oncol. 2013 Sep 20;31(27):3432-8. doi: 10.1200/JCO.2013.49.4823. Epub 2013 Aug 19.

PMID:
23960185
2.

Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.

Lyss AP, Lilenbaum RC.

Clin Lung Cancer. 2009 Nov;10(6):410-3. doi: 10.3816/CLC.2009.n.077.

PMID:
19900858
3.

A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.

Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SA.

J Am Coll Surg. 2004 Oct;199(4):644-51.

PMID:
15454152
4.

Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.

Galsky MD, Hendricks R, Svatek R, Bangs R, Hoffman-Censits J, Clement J, Dreicer R, Guancial E, Hahn N, Lerner SP, O'Donnell PH, Quale DZ, Siefker-Radtke A, Shipley W, Sonpavde G, Vaena D, Vinson J, Rosenberg J.

Cancer. 2013 Jun 1;119(11):1994-8. doi: 10.1002/cncr.27973. Epub 2013 Mar 1.

5.

Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?

Yee KW, Pater JL, Pho L, Zee B, Siu LL.

J Clin Oncol. 2003 Apr 15;21(8):1618-23.

PMID:
12697888
6.

Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials.

Cheng SK, Dietrich MS, Dilts DM.

Clin Cancer Res. 2011 Apr 1;17(7):1947-55. doi: 10.1158/1078-0432.CCR-10-1730. Epub 2011 Mar 29.

7.

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, Kaplan R, Smith M, Ungerleider R, Christian MC.

J Clin Oncol. 2002 Apr 15;20(8):2109-17.

PMID:
11956272
8.

Clinical trial accrual among new cancer patients at a community-based cancer center.

Go RS, Frisby KA, Lee JA, Mathiason MA, Meyer CM, Ostern JL, Walther SM, Schroeder JE, Meyer LA, Umberger KE.

Cancer. 2006 Jan 15;106(2):426-33.

9.

Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].

Krempien R, Muenter MW, Huber PE, Nill S, Friess H, Timke C, Didinger B, Buechler P, Heeger S, Herfarth KK, Abdollahi A, Buchler MW, Debus J.

BMC Cancer. 2005 Oct 11;5:131.

10.

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, Warnecke R, Ford L.

J Natl Cancer Inst. 1993 Dec 1;85(23):1945-50.

PMID:
8230286
11.

Representation of older patients in cancer treatment trials.

Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA.

Cancer. 1994 Oct 1;74(7 Suppl):2208-14.

PMID:
8087794
12.

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.

Kimmick GG, Peterson BL, Kornblith AB, Mandelblatt J, Johnson JL, Wheeler J, Heinze R, Cohen HJ, Muss HB.

J Clin Oncol. 2005 Apr 1;23(10):2201-7.

PMID:
15800312
13.

Enrollment in clinical cancer trials: how are we doing and what are the obstacles to improving enrollment rates? A 2-year retrospective review of pediatric cancer trial enrollment in New Zealand.

Dodgshun AJ, De Silva MP, Bradbeer P, Cross S.

J Pediatr Hematol Oncol. 2014 Nov;36(8):630-4. doi: 10.1097/MPH.0000000000000123.

PMID:
24577541
15.

Accrual to cancer clinical trials: directions from the research literature.

Gotay CC.

Soc Sci Med. 1991;33(5):569-77. Review.

PMID:
1962228
16.

Pancreatic neoplasm in 2011: an update.

Saif MW.

JOP. 2011 Jul 8;12(4):316-21. Review.

17.

Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.

Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, Lucci A, Green B, Ota D, Nelson H; American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.

Cancer. 2006 Jan 1;106(1):188-95.

18.

Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007.

Korn EL, Freidlin B, Mooney M, Abrams JS.

J Clin Oncol. 2010 Dec 10;28(35):5197-201. doi: 10.1200/JCO.2010.31.5382. Epub 2010 Nov 8.

19.

Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.

Movsas B, Moughan J, Owen J, Coia LR, Zelefsky MJ, Hanks G, Wilson JF.

Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1145-50. Epub 2007 Apr 9.

PMID:
17418963
20.

Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.

Klabunde C, Kaluzny A, Ford L.

Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):783-9.

Supplemental Content

Support Center